Hikma Pharmaceuticals (HIK)

Sector:

Pharma and Biotech

Index:

FTSE 100

1,974.00p
   
  • Change Today:
    -17.00p
  • 52 Week High: 2,340.00
  • 52 Week Low: 1,772.00
  • Currency: UK Pounds
  • Shares Issued: 234.72m
  • Volume: 205,417
  • Market Cap: £4,633.37m
  • RiskGrade: 125

Broker List

Order by
Date Broker name New Price Old price target New price target Broker change
10-Mar-25 Berenberg Bank Buy 2,118.00p - 2,560.00p Reiteration
07-Mar-25 JP Morgan Cazenove Overweight 2,124.00p - - Reiteration
18-Jun-24 Deutsche Buy 1,999.00p - 2,750.00p Reiteration
07-May-24 Barclays Equal-weight 1,956.00p - 2,000.00p Reiteration
13-Nov-23 RBC Capital Markets Sector perform 1,767.50p - 2,150.00p Reiteration
03-Oct-23 Citigroup Buy 2,053.00p - - Reiteration
22-May-23 Jefferies Buy 1,841.00p 2,080.00p 2,125.00p Reiteration
11-May-22 Morgan Stanley Equal-weight 1,729.50p - - Reiteration

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Consensus broker estimates sourced from FactSet Research Systems Inc., who calculate consensus using only those estimates changed or actively validated within the last 75 days.

 

HIK Market Data

Currency UK Pounds
Share Price 1,974.00p
Change Today -17.00p
% Change -0.85 %
52 Week High 2,340.00
52 Week Low 1,772.00
Volume 205,417
Shares Issued 234.72m
Market Cap £4,633.37m
RiskGrade 125

HIK Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
90.16% below the market average90.16% below the market average90.16% below the market average90.16% below the market average90.16% below the market average
34.78% below the sector average34.78% below the sector average34.78% below the sector average34.78% below the sector average34.78% below the sector average
Price Trend
20.71% above the market average20.71% above the market average20.71% above the market average20.71% above the market average20.71% above the market average
34.78% above the sector average34.78% above the sector average34.78% above the sector average34.78% above the sector average34.78% above the sector average
Income
0.55% above the market average0.55% above the market average0.55% above the market average0.55% above the market average0.55% above the market average
71.43% above the sector average71.43% above the sector average71.43% above the sector average71.43% above the sector average71.43% above the sector average
Growth
38.26% above the market average38.26% above the market average38.26% above the market average38.26% above the market average38.26% above the market average
6.25% above the sector average6.25% above the sector average6.25% above the sector average6.25% above the sector average6.25% above the sector average

What The Brokers Say

Strong Buy 6
Buy 3
Neutral 3
Sell 0
Strong Sell 0
Total 12
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

HIK Dividends

  Latest Previous
  Final Interim
Ex-Div 20-Mar-25 15-Aug-24
Paid 01-May-25 20-Sep-24
Amount 48.00¢ 32.00¢

Trades for 16-Jul-2025

Time Volume / Share Price
15:45 0 @ 1,982.00p
15:47 0 @ 1,982.00p
15:33 0 @ 1,982.00p
15:18 0 @ 1,982.00p
15:18 0 @ 1,982.00p

HIK Key Personnel

CEO Riad Mishlawi

Top of Page